LindaA.DiMeglioMDMPH

Pediatric Bone Metabolism Disorders, Pediatric Diabetes Endocrinology

Professor of Pediatrics, Indiana University, Riley Hospital for Children

Dr. DiMeglio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
705 Riley Hospital Dr
Ri 5960
Indianapolis, IN 46202
Phone+1 317-944-3889

Fax+1 317-944-3882

Dr. Linda DiMeglio is a highly accomplished Pediatric Endocrinologist located in Indianapolis, IN, specializing in Pediatric Bone Metabolism Disorders and Pediatric Diabetes Endocrinology. Her medical education journey includes a residency at the McGaw Medical Center of Northwestern University, a fellowship in Pediatric Endocrinology at Indiana University School of Medicine, and graduating from the Perelman School of Medicine at the University of Pennsylvania. Since 2010, she has been working as a Professor at Riley Hospital for Children at IU Health. Dr. DiMeglio has contributed significantly to her field, with numerous articles and papers published in esteemed journals such as The Lancet and Journal of the Pediatric Infectious Diseases Society. She also contributed to several clinical trials focusing broadly on the management of Type 1 Diabetes. Dr. DiMeglio's work has earned her numerous accolades, including America's Top Doctors from Castle Connolly and a fellow from the American Academy of Pediatrics.

Indiana University School of MedicineFellowship, Pediatric Endocrinology, 1996 - 1999
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 1993 - 1996
Perelman School of Medicine at the University of PennsylvaniaClass of 1993

PubMed

444 citations
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio
The New England Journal of Medicine. 2019-06-09
40 citations
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring.
Martin Tauschmann, Gregory Forlenza, Korey Hood, Roque Cardona-Hernandez, Elisa Giani
Pediatric Diabetes. 2022-12-01
81 citations
ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes.
Martin de Bock, Ethel Codner, Maria E Craig, Tony Huynh, David M Maahs
Pediatric Diabetes. 2022-12-01

Landmark International Consensus Guidance Provides a Framework for Clinicians to Monitor Those in Early-Stage Type 1 DiabetesJune 24th, 2024
Type 1 Diabetes: Recent Wins and Ongoing Challenges on the Road to a CureMay 24th, 2023
Clinical Study Reveals New Use for High Blood Pressure Drug in Pediatric PatientsMarch 1st, 2023
Join now to see all

Type 1 Diabetes Trialnet At Indiana University Clinical CenterNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
Pathogenesis Of Osteoporosis In Young Children With Cystic FibrosisNational Center For Research Resources2004–2008
Oral Bisphosphonate Therapy For Adults With Osteogenesis ImperfectaNational Center For Research Resources2004–2008
Bisphosphonate Therapy For Childhood OsteoporosisNational Center For Research Resources2004–2008
Bisphosphonate Therapy For Osteogenesis ImperfectaNational Center For Research Resources2000–2008
Biphosphonate Therapy For Osteogenesis ImperfectaNational Center For Research Resources2004–2006
Continuous Insulin Infusion Versus Insulin Injection TherapyNational Center For Research Resources2005
Mentored Patient Oriented Research Career Development AwNational Center For Research Resources2000–2004